At Karo, we’re expressing our deepest concern and empathy for the Ukrainian people and condemning this act of violence from the Russian leadership. Learn about our aid initiatives to support the people of Ukraine here.
Most of us define our health as above average.
Yet, 97% live with everyday health issues such as e.g. stress, sleep issues and digestive problems*.
Imagine how great life would be if we didn’t have to live with such issues.
So let’s decide not to.
Karo Pharma delivers smart choices that give people control over their everyday healthcare.
*IPSOS “Self Care: Be Your Best” Report, 2019
“The itching has been going for so long, I was starting to accept that this was just my skin.”
– Male, Norway
Probiotics: The natural way to boost your wellbeing
“I noticed my hemorrhoids as an early teen, but didn’t do anything about it for years.”
– Male, UK
“The cortisone cream was a game changer for me. I felt the difference immediately.”
– Male, Norway
1 out of 5 adults live with toenail fungus
– Global Nail Fungus Organization 2019
“We’ve made it our purpose to develop reliable ways for people to treat their everyday ailments, to help them live healthier lives. We call it smart choices for everyday healthcare.”
Christoffer Lorenzen, CEO, Karo Pharma
Karo Pharma Aktiebolag’s application for de-listing has been approved
Karo Pharma Aktiebolag’s (“Karo Pharma” or the “Company”) application for de-listing has now been approved by Nasdaq. The last day…
Karo Pharma Aktiebolag applies for de-listing
The Board of Directors of Karo Pharma Aktiebolag (“Karo Pharma” or the “Company”) has resolved to apply for de-listing of…
Karo Intressenter AB initiates compulsory redemption
On 16 August 2022, Karo Intressenter AB (“Karo Intressenter”) announced a public cash offer to the shareholders in Karo Pharma…
Interim report H1 2022
January – June · Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the…
Karo Pharma publishes the 2021 annual report
Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karopharma.com. For…
Year-end report 2021
Q4, October – December · Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period.·…
We support Operation Smile
Every three minutes, a child with cleft lip or palate is born. These children often live a tough life, having to endure harassment and isolation.
Operation Smile perform about 15,000 surgeries a year – improving the lives of just as many children all over the world. For us this is a smart choice for everyday healthcare and why Karo Pharma has supported Operation Smile since 2018.
You can read more about the medical missions in Malawi, Mozambique and Ghana, which our backing made possible, in our Annual Report.